Literature DB >> 2614682

A semiparametric approach to physiological flow models.

D Verotta1, L B Sheiner, W F Ebling, D R Stanski.   

Abstract

By regarding sampled tissues in a physiological model as linear subsystems, the usual advantages of flow models are preserved while mitigating two of their disadvantages, (i) the need for assumptions regarding intratissue kinetics, and (ii) the need to simultaneously fit data from several tissues. To apply the linear systems approach, both arterial blood and (interesting) tissue drug concentrations must be measured. The body is modeled as having an arterial compartment (A) distributing drug to different linear subsystems (tissues), connected in a specific way by blood flow. The response (CA, with dimensions of concentration) of A is measured. Tissues receive input from A (and optionally from other tissues), and send output to the outside or to other parts of the body. The response (CT, total amount of drug in the tissue (T) divided by the volume of T) from the T-th one, for example, of such tissues is also observed. From linear systems theory, CT can be expressed as the convolution of CA with a disposition function, F(t) (with dimensions 1/time). The function F(t) depends on the (unknown) structure of T, but has certain other constant properties: The integral integral infinity0 F(t) dt is the steady state ratio of CT to CA, and the point F(0) is the clearance rate of drug from A to T divided by the volume of T. A formula for the clearance rate of drug from T to outside T can be derived. To estimate F(t) empirically, and thus mitigate disadvantage (i), we suggest that, first, a nonparametric (or parametric) function be fitted to CA data yielding predicted values, CA, and, second, the convolution integral of CA with F(t) be fitted to CT data using a deconvolution method. By so doing, each tissue's data are analyzed separately, thus mitigating disadvantage (ii). A method for system simulation is also proposed. The results of applying the approach to simulated data and to real thiopental data are reported.

Entities:  

Mesh:

Year:  1989        PMID: 2614682     DOI: 10.1007/bf01061458

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  23 in total

1.  Theorems on linear systems.

Authors:  J Z HEARON
Journal:  Ann N Y Acad Sci       Date:  1963-05-10       Impact factor: 5.691

Review 2.  An inequality-constrained least-squares deconvolution method.

Authors:  D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

3.  Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.

Authors:  M S Roberts; J D Donaldson; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1988-02

4.  Comments on mean residence time determination.

Authors:  E M Landaw; D Katz
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

5.  Drug kinetics in low-flux (small) anatomic compartments.

Authors:  D A Noe; K M Kumor
Journal:  J Pharm Sci       Date:  1983-06       Impact factor: 3.534

6.  Numerical deconvolution by least squares: use of prescribed input functions.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

7.  Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.

Authors:  N Benowitz; F P Forsyth; K L Melmon; M Rowland
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

8.  Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

9.  A novel pharmacokinetic method for analysis of placental transfer of latamoxef in humans.

Authors:  T Yamamoto; J Yasuda; M Kanao; H Okada; T Oguma; H Yamada
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

10.  A physiologically based pharmacokinetic model for theophylline disposition in the pregnant and nonpregnant rat.

Authors:  J L Gabrielsson; L K Paalzow; L Nordström
Journal:  J Pharmacokinet Biopharm       Date:  1984-04
View more
  12 in total

1.  Quantitative structure-pharmacokinetics relationships: II. A mechanistically based model to evaluate the relationship between tissue distribution parameters and compound lipophilicity.

Authors:  I Nestorov; L Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

Review 2.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Mean time parameters for generalized physiological flow models (semihomogeneous linear systems).

Authors:  D Verotta; L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1991-06

4.  Commentary on "Physiologically based pharmacokinetic modeling as a tool for drug development".

Authors:  T M Ludden; W R Gillespie; W J Bachman
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

5.  Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model.

Authors:  S Björkman; D R Stanski; H Harashima; R Dowrie; S R Harapat; D R Wada; W F Ebling
Journal:  J Pharmacokinet Biopharm       Date:  1993-06

6.  Two constrained deconvolution methods using spline functions.

Authors:  D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1993-10

7.  Estimation and model selection in constrained deconvolution.

Authors:  D Verotta
Journal:  Ann Biomed Eng       Date:  1993 Nov-Dec       Impact factor: 3.934

8.  Analyzing multi-response data using forcing functions.

Authors:  Liping Zhang; Lewis B Sheiner
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-11-07       Impact factor: 2.745

9.  Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.

Authors:  G E Blakey; I A Nestorov; P A Arundel; L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-06

10.  Pharmacokinetic differentiation of drug candidates using system analysis and physiological-based modelling. Comparison of C.E.R.A. and erythropoietin.

Authors:  Peter Veng-Pedersen; Kevin J Freise; Robert L Schmidt; John A Widness
Journal:  J Pharm Pharmacol       Date:  2008-10       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.